Nidazea (Metronidazole)

Metronidazole, the active ingredient in Nidazea, is a nitroimidazole antibiotic presented as a topical formulation for topical use. It is employed to manage certain skin conditions caused by bacteria or protozoa, particularly in adults. GNH USA supplies Nidazea as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used in dermatology to treat infections and inflammatory skin disorders. - Rosacea: reduces inflammatory papules, pustules and persistent facial redness. - Acanthosis nigricans: improves hyperpigmented, velvety plaques on skin folds. - Acne vulgaris: decreases bacterial load and inflammation, leading to fewer lesions. - Dermatologic infections: treats bacterial or protozoal skin infections, promoting lesion resolution.

Metronidazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: localized redness or burning at the application site. - Dryness: mild desquamation or flaking of treated skin. - Pruritus: transient itching sensations. - Contact dermatitis: allergic skin reaction in sensitive individuals. - Taste alteration: occasional metallic taste when applied near oral mucosa.

Serious or Rare Side Effects: - Severe hypersensitivity: angioedema, swelling of face or throat. - Stevens‑Johnson syndrome: rare severe skin blistering. - Neurotoxicity: peripheral neuropathy or dizziness with extensive use. - Hematologic changes: unexplained anemia or leukopenia. - Hepatotoxicity: elevated liver enzymes in susceptible patients.

Before using Nidazea, consider the following safety measures. - Pregnancy: Category B3 – use only if potential benefit justifies potential risk to the fetus. - Breastfeeding: consult a healthcare professional; minimal systemic absorption is expected. - Skin integrity: avoid application on broken or severely inflamed skin. - Allergies: discontinue use if signs of allergic reaction develop. - Concomitant medications: inform prescriber of all topical or systemic drugs. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metronidazole can interact with other agents, affecting efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with flushing and nausea. - Warfarin: increased anticoagulant effect, raising bleeding risk. - Lithium: potential for increased lithium toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenytoin: possible reduction in metronidazole effectiveness. - Other topical antibiotics: assess for additive skin irritation.